212 related articles for article (PubMed ID: 30806515)
1. Circulating biomarkers for high-grade glioma.
Loo HK; Mathen P; Lee J; Camphausen K
Biomark Med; 2019 Feb; 13(3):161-165. PubMed ID: 30806515
[No Abstract] [Full Text] [Related]
2. Circulating MicroRNAs as Potential Biomarkers in Glioma: A Mini-Review.
Choppavarapu L; Kandi SM
Endocr Metab Immune Disord Drug Targets; 2021; 21(2):195-202. PubMed ID: 32744979
[TBL] [Abstract][Full Text] [Related]
3. Serum microRNA is a biomarker for post-operative monitoring in glioma.
Morokoff A; Jones J; Nguyen H; Ma C; Lasocki A; Gaillard F; Bennett I; Luwor R; Stylli S; Paradiso L; Koldej R; Paldor I; Molania R; Speed TP; Webb A; Infusini G; Li J; Malpas C; Kalincik T; Drummond K; Siegal T; Kaye AH
J Neurooncol; 2020 Sep; 149(3):391-400. PubMed ID: 32915353
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
5. Serum microRNAs as potential noninvasive biomarkers for glioma.
Yu X; Li Z
Tumour Biol; 2016 Feb; 37(2):1407-10. PubMed ID: 26628296
[TBL] [Abstract][Full Text] [Related]
6. Identification of miRNA signatures in serum exosomes as a potential biomarker after radiotherapy treatment in glioma patients.
Li Z; Ye L; Wang L; Quan R; Zhou Y; Li X
Ann Diagn Pathol; 2020 Feb; 44():151436. PubMed ID: 31865249
[TBL] [Abstract][Full Text] [Related]
7. Potential Diagnostic and Prognostic Value of Plasma Circulating MicroRNA-182 in Human Glioma.
Xiao Y; Zhang L; Song Z; Guo C; Zhu J; Li Z; Zhu S
Med Sci Monit; 2016 Mar; 22():855-62. PubMed ID: 26978735
[TBL] [Abstract][Full Text] [Related]
8. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
[TBL] [Abstract][Full Text] [Related]
9. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNA biomarkers for glioma and predicting response to therapy.
Tumilson CA; Lea RW; Alder JE; Shaw L
Mol Neurobiol; 2014 Oct; 50(2):545-58. PubMed ID: 24696266
[TBL] [Abstract][Full Text] [Related]
11. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
[TBL] [Abstract][Full Text] [Related]
12. LGI1 tumor tissue expression and serum autoantibodies in patients with primary malignant glioma.
Dazzo E; Pasini E; Furlan S; de Biase D; Martinoni M; Michelucci R; Nobile C;
Clin Neurol Neurosurg; 2018 Jul; 170():27-33. PubMed ID: 29723732
[TBL] [Abstract][Full Text] [Related]
13. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma.
Wang Q; Li P; Li A; Jiang W; Wang H; Wang J; Xie K
J Exp Clin Cancer Res; 2012 Nov; 31(1):97. PubMed ID: 23174013
[TBL] [Abstract][Full Text] [Related]
14. Plasma miR-454-3p as a potential prognostic indicator in human glioma.
Shao N; Wang L; Xue L; Wang R; Lan Q
Neurol Sci; 2015 Feb; 36(2):309-13. PubMed ID: 25190548
[TBL] [Abstract][Full Text] [Related]
15. Circulating Biomarkers for Glioma: A Review.
Jones J; Nguyen H; Drummond K; Morokoff A
Neurosurgery; 2021 Feb; 88(3):E221-E230. PubMed ID: 33442748
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum extracellular vesicles as noninvasive diagnostic markers of glioma.
Wang H; Jiang D; Li W; Xiang X; Zhao J; Yu B; Wang C; He Z; Zhu L; Yang Y
Theranostics; 2019; 9(18):5347-5358. PubMed ID: 31410219
[No Abstract] [Full Text] [Related]
17. Diagnostic and Prognostic Potential of Serum Cell-Free microRNA-214 in Glioma.
Wang J; Che F; Zhang J; Zhang M; Xiao S; Liu Y; Zhou L; Su Q; You C; Lu Y; Heng X
World Neurosurg; 2019 May; 125():e1217-e1225. PubMed ID: 30794970
[TBL] [Abstract][Full Text] [Related]
18. Alu methylation serves as a biomarker for non-invasive diagnosis of glioma.
Chen J; Huan W; Zuo H; Zhao L; Huang C; Liu X; Hou S; Qi J; Shi W
Oncotarget; 2016 May; 7(18):26099-106. PubMed ID: 27028997
[TBL] [Abstract][Full Text] [Related]
19. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
[TBL] [Abstract][Full Text] [Related]
20. Micro RNA Molecules as Modulators of Treatment Resistance, Immune Checkpoints Controllers and Sensitive Biomarkers in Glioblastoma Multiforme.
Mazurek M; Litak J; Kamieniak P; Osuchowska I; Maciejewski R; Roliński J; Grajkowska W; Grochowski C
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
